title: Multiple myeloma.
abstract: This article presents a review of multiple myeloma, precursor states, and related plasma cell disorders. The clinical roles of fluorodeoxyglucose PET/computed tomography (CT) and the potential to improve the management of patients with multiple myeloma are discussed. The clinical and research data supporting the utility of PET/CT use in evaluating myeloma and other plasma cell dyscrasias continues to grow.
authors.affiliation: Eka Medical Center - Jakarta, Central Business District Lot IX, BSD City, Tangerang 15321, Indonesia. Electronic address: ppeller11@gmail.com.
authors.forename: Patrick J
authors.initials: PJ
authors.lastname: Peller
mesh_terms: D000368:Aged; D018450:Disease Progression; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008297:Male; D008875:Middle Aged; D064847:Multimodal Imaging / Q000379:methods; D009101:Multiple Myeloma / Q000473:pathology* / Q000628:therapy; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D010265:Paraproteinemias / Q000473:pathology / Q000628:therapy; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals; D014057:Tomography, X-Ray Computed / Q000379:methods*
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18
keywords: Fluorodeoxyglucose; Monoclonal gammopathy; Multiple myeloma; PET; PET/CT; Plasmacytoma